Metformin in non-diabetic patients with autosomal dominant polycystic kidney disease: a systematic review and meta-analysis of randomized controlled trials.

BMC Nephrol · 2025 · PMC12625526 · PMID 41254555

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

Nevertheless, the numerically less pronounced decline in the metformin group may suggest a possible trend toward kidney protection, though this finding should be interpreted with caution.

also in 948 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.